These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Immediate results of treatment of tuberculosis patients with drugs of the second series]. Ivanova ES, Komarova AA. Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339 [No Abstract] [Full Text] [Related]
23. [Therapy of pulmonary tuberculosis with reserve drugs in the light of our personal observations]. Kochnowski G. Wiad Lek; 1970 Jan 01; 23(1):9-13. PubMed ID: 4312765 [No Abstract] [Full Text] [Related]
24. [Triple drug regimen with reserve drugs: ETA, PZA and CS in the treatment of chronic pulmonary tuberculosis]. Wagner J. Gruzlica; 1966 Mar 01; 34(3):249-54. PubMed ID: 5947778 [No Abstract] [Full Text] [Related]
29. Cycloserine in the treatment of pulmonary tuberculosis. Aceves Ortega R, Cortés de la Peña F, Sanchez Ceceña S, Arreola Chavez C. Scand J Respir Dis Suppl; 1970 Mar 01; 71():109-14. PubMed ID: 5271969 [No Abstract] [Full Text] [Related]
30. Limitations of the clinical activity of cycloserine therapy. Appearance of resistance to cycloserine when used alone and in combination with other drugs. Molina C. Scand J Respir Dis Suppl; 1970 Mar 01; 71():296-305. PubMed ID: 5272000 [No Abstract] [Full Text] [Related]
31. [Effectiveness of the agents of the 2d series in treating patients with chronic destructive tuberculosis of the lungs]. Utkin VV. Probl Tuberk; 1973 Mar 01; 51(1):12-6. PubMed ID: 4727151 [No Abstract] [Full Text] [Related]
32. Results of treatment of patients with pulmonary tuberculous with a combination of cycloserine and other tuberculostatics. Raboukhine A. Scand J Respir Dis Suppl; 1970 Mar 01; 71():155-8. PubMed ID: 5271977 [No Abstract] [Full Text] [Related]
33. Should isoniazid be used in retreatment of tuberculosis despite acquired isoniazid resistance? Moulding TS. Am Rev Respir Dis; 1981 Mar 01; 123(3):262-4. PubMed ID: 6784621 [Abstract] [Full Text] [Related]
34. [Preparations of the 2d series in the complex treatment of middle-aged and elderly patients with pulmonary tuberculosis]. Iaschenko BP. Probl Tuberk; 1967 Mar 01; 45(9):21-6. PubMed ID: 4303748 [No Abstract] [Full Text] [Related]
35. Clinical efficiency of cycloserine in association with other tuberculostatics. Anastasatu C, Ulpian C, Weiss P. Scand J Respir Dis Suppl; 1970 Mar 01; 71():152-4. PubMed ID: 5271976 [No Abstract] [Full Text] [Related]
36. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis]. Zanotelli F, Perusi O. G Ital Mal Torace; 1966 Mar 01; 20(6):365-78. PubMed ID: 5997781 [No Abstract] [Full Text] [Related]
37. Retreatment of tuberculosis patients with combined drug therapy. Feldman J. Geriatrics; 1969 Nov 01; 24(11):92-4. PubMed ID: 5349362 [No Abstract] [Full Text] [Related]
38. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs]. Pannain M, Tarantino AB, Mac Dowell A, Costa JA, Cunha JM, Pantoja W. Rev Bras Med; 1967 Aug 01; 24(8):664-8. PubMed ID: 5603007 [No Abstract] [Full Text] [Related]
39. Pulmonary alveolar proteinosis. Treatment in a case complicated by tuberculosis. Ramirez J. Am Rev Respir Dis; 1967 Mar 01; 95(3):491-5. PubMed ID: 6066626 [No Abstract] [Full Text] [Related]
40. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients. Mital OP, Agarwala MC, Singh SK. Indian J Chest Dis; 1967 Oct 01; 9(4):196-206. PubMed ID: 4323543 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]